Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4514

1.

Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.

Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.

J Urol. 2005 Dec;174(6):2181-5.

PMID:
16280760
[PubMed - indexed for MEDLINE]
2.

Prognostic significance of lymphovascular invasion in clinically localized prostate cancer after radical prostatectomy.

Baydar DE, Baseskioglu B, Ozen H, Geyik PO.

ScientificWorldJournal. 2008 Mar 17;8:303-12. doi: 10.1100/tsw.2008.49.

PMID:
18379707
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

PMID:
20883488
[PubMed - indexed for MEDLINE]
5.

Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.

Wheeler TM, Dillioglugil O, Kattan MW, Arakawa A, Soh S, Suyama K, Ohori M, Scardino PT.

Hum Pathol. 1998 Aug;29(8):856-62.

PMID:
9712429
[PubMed - indexed for MEDLINE]
6.

Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.

Noguchi M, Stamey TA, McNeal JE, Yemoto CM.

J Urol. 2000 Nov;164(5):1596-600.

PMID:
11025712
[PubMed - indexed for MEDLINE]
7.
8.

Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.

Ferrari MK, McNeal JE, Malhotra SM, Brooks JD.

Urology. 2004 Oct;64(4):749-53.

PMID:
15491714
[PubMed - indexed for MEDLINE]
9.

Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.

Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ.

J Urol. 2002 Jul;168(1):110-5.

PMID:
12050502
[PubMed - indexed for MEDLINE]
10.

Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion.

Sofer M, Savoie M, Kim SS, Civantos F, Soloway MS.

J Urol. 2003 Jan;169(1):153-6.

PMID:
12478125
[PubMed - indexed for MEDLINE]
11.

The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.

Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.

Hum Pathol. 2007 Aug;38(8):1207-11. Epub 2007 May 8.

PMID:
17490720
[PubMed - indexed for MEDLINE]
12.

Prognostic impact of lymphovascular invasion in radical prostatectomy specimens.

May M, Kaufmann O, Hammermann F, Loy V, Siegsmund M.

BJU Int. 2007 Mar;99(3):539-44. Epub 2006 Nov 28.

PMID:
17155973
[PubMed - indexed for MEDLINE]
13.

Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence.

Jones TD, Koch MO, Lin H, Cheng L.

BJU Int. 2005 Dec;96(9):1253-7.

PMID:
16287440
[PubMed - indexed for MEDLINE]
14.

Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.

Gettman MT, Pacelli A, Slezak J, Bergstralh EJ, Blute M, Zincke H, Bostwick DG.

Urology. 1999 Sep;54(3):479-85.

PMID:
10475358
[PubMed - indexed for MEDLINE]
15.

Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.

Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC Jr; SEARCH Database Study Group.

J Urol. 2003 Jun;169(6):2136-41.

PMID:
12771735
[PubMed - indexed for MEDLINE]
16.

Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.

Yossepowitch O, Sircar K, Scardino PT, Ohori M, Kattan MW, Wheeler TM, Reuter VE.

J Urol. 2002 Nov;168(5):2011-5.

PMID:
12394697
[PubMed - indexed for MEDLINE]
17.

[Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].

Feyaerts A, Delrée A, Lorge F, Opsomer RJ, Wese FX, Van Cangh PJ, Draguet AP, Cosyns JP.

Acta Urol Belg. 1997 Mar;65(1):11-8. French.

PMID:
9245198
[PubMed - indexed for MEDLINE]
18.

Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.

D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP.

J Urol. 2001 Jan;165(1):126-9.

PMID:
11125380
[PubMed - indexed for MEDLINE]
19.

Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.

Palapattu GS, Allaf ME, Trock BJ, Epstein JI, Walsh PC.

J Urol. 2004 Nov;172(5 Pt 1):1860-4.

PMID:
15540739
[PubMed - indexed for MEDLINE]
20.

Familial prostate cancer: a different disease?

Kupelian PA, Klein EA, Witte JS, Kupelian VA, Suh JH.

J Urol. 1997 Dec;158(6):2197-201.

PMID:
9366343
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk